6Heathcote EJ.Magement of primary biliary cirrhosis.The American Association for the Study of Liver DiseaLses practice guidelines.Hepatology,2000,31:1005-1013.
2HEATHCOTE EJ.Management of primary biliary cirrhosis[J].Hepatology,2000,31:1005.
3SILVEIRA MG,LINDOR KD.Treatment of primary biliary cirrhosis:therapy with choleretie and immunosuppressive agents[J].Clin Liver Dis,2008,12:425.
4LARUSSO NF,SHNEIDER BL,BLACK D,et al.Primary sclerosing cholangitis:summary of a workshop[J].Hepatology,2006,44:746.
5ISHIBASHI H,KOMORI A,SHIMODA S,et al.Guidelines for therapy of autoimmun'e liver disease[J].Semin Liver Dis,2007,27:214.
6LU SC,MATO JM.S-adenosylmethionine in cell growth,apoptosis and liver cancer[J].J Gastroenterol and Hepatol,2008,(Suppl 1):S73.
7BINDER T,SALAJ P,ZIMA T,et al.Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy[J].J Perinat Med,2006,34:383.
8MATO J M,LU SC.Role of S-adenosyl-l-methionine in liver health and injury[J].Hepatology,2007,45:1306.
9GUGLIELMI FW,REGANO N,MAZZUOLI S,et al.Cholestasis induced by total parenteral nutrition[J].Clin Liver Dis,2008,12:97.
10PAUMGARTNER G,PUSL T.Medical treatment of cholestatic liver disease[J].Clin Liver Dis,2008,12:53.
